EUVIMEDEUVIMED entdecken
Crossref

NMR-based serum metabolomics reveals diabetes-linked metabolic reprogramming in early-stage chronic kidney disease

Upasna Gupta, Amrita Sahu, Anupama Kaul, Jiya Mishra, Subash Chandra Yadav, Manas Behera, Bikash Baishya, Neeraj Sinha

Journal of Pharmaceutical and Biomedical Analysis · 2026-08 · 276 · 117475

DOI: 10.1016/j.jpba.2026.117475 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2026-08. Verfasst von Upasna Gupta und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Biomedical Research, Sanjay Gandhi Post Institute of Medical Sciences Campus, Raebareli Road, Lucknow, Uttar Pradesh 226014, India; Academy…. Hauptthemen laut MEDLINE: Metabolomics, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic, Diabetic Nephropathies. Die Arbeit nennt 48 Literaturangaben. Gefördert von: Defence Science and Technology Group, Defence Research and Development Organisation, Centro de Investigação em Biomedicina.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early-stage chronic kidney disease (CKD) is usually asymptomatic, and the presence of type 2 diabetes mellitus (T2DM) accelerates metabolic alterations long before conventional clinical markers detect changes. Despite their strong clinical association, the metabolic differences between early-stage non-diabetic CKD and diabetic CKD remain poorly understood, limiting early diagnosis and risk stratification. To identify disease-specific metabolic alterations and potential biomarkers, we employed quantitative proton NMR (¹H NMR) serum metabolomics (n = 100) in early-stage CKD (G1-G3B) patients, utilising untargeted polar metabolite profiling. Univariate and multivariate analyses (PCA, PLS-DA, Random Forest) clearly distinguished between diabetic CKD and non-diabetic CKD. Patients with diabetic CKD had lower levels of methionine, serine, and citrate, suggesting an early disturbance of energy and one-carbon metabolism. The ROC analysis (AUC = 0.77) showed a moderate level of diagnostic accuracy. Pathway enrichment analysis identified dysregulation of the tricarboxylic acid (TCA) cycle, pyruvate metabolism, glycine-serine-threonine metabolism, cysteine-methionine metabolism, and the one-carbon pool mediated by folate. Linear regression trend analyses across early-stage non-diabetic CKD, prediabetic CKD, and diabetic CKD revealed a gradual metabolic decline correlating with increasing glycemic burden. Collectively, these findings identify early metabolic signatures that elucidate the interplay between diabetic CKD and non- diabetic CKD, supporting improved patient stratification and targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MetabolomicsDiabetes Mellitus, Type 2Renal Insufficiency, ChronicDiabetic NephropathiesHumansBiomarkersMaleFemaleMiddle AgedMetabolic ReprogrammingMagnetic Resonance SpectroscopyAgedEarly DiagnosisROC Curve

Stichwörter der Autor:innen

(1)H NMR spectroscopyBiomarkersDiabetesEarly diagnosisEarly-stage CKDMetabolomics

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Centre of Biomedical Research, Sanjay Gandhi Post Institute of Medical Sciences Campus, Raebareli Road, Lucknow, Uttar Pradesh 226014, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad 201002, Indi…
  • Department of Nephrology and Renal Transplantation, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh 226014, India. Electronic address: anupa@sgpgi.ac.in.
  • Department of Endocrinology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh 226014, India.
  • Department of Nephrology and Renal Transplantation, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, Uttar Pradesh 226014, India.

Förderung

  • Defence Science and Technology Group
  • Defence Research and Development Organisation
  • Centro de Investigação em Biomedicina
  • Life Sciences Research Board

Zitieren

APA

Gupta, U., Sahu, A., Kaul, A., Mishra, J., Yadav, S. C., Behera, M., Baishya, B., & Sinha, N. (2026). NMR-based serum metabolomics reveals diabetes-linked metabolic reprogramming in early-stage chronic kidney disease. Journal of Pharmaceutical and Biomedical Analysis, 276, 117475. https://doi.org/10.1016/j.jpba.2026.117475

Vancouver

Gupta U, Sahu A, Kaul A, Mishra J, Yadav SC, Behera M, et al. NMR-based serum metabolomics reveals diabetes-linked metabolic reprogramming in early-stage chronic kidney disease. Journal of Pharmaceutical and Biomedical Analysis. 2026;276:117475. doi:10.1016/j.jpba.2026.117475

BibTeX
@article{Gupta2026,
  author = {Gupta, Upasna and Sahu, Amrita and Kaul, Anupama and Mishra, Jiya and Yadav, Subash Chandra and Behera, Manas and Baishya, Bikash and Sinha, Neeraj},
  title = {NMR-based serum metabolomics reveals diabetes-linked metabolic reprogramming in early-stage chronic kidney disease},
  journal = {Journal of Pharmaceutical and Biomedical Analysis},
  year = {2026},
  volume = {276},
  pages = {117475},
  doi = {10.1016/j.jpba.2026.117475}
}
Kostenlos starten →